Literature DB >> 30309642

Radiation-Induced Liver Disease and Modern Radiotherapy.

Eugene J Koay1, Dawn Owen2, Prajnan Das3.   

Abstract

Modern radiotherapy techniques have enabled high focal doses of radiation to be delivered to patients with primary and secondary malignancies of the liver. The current clinical practice of radiation oncology has benefitted from decades of research that have informed how to achieve excellent local control and survival outcomes with minimal toxicities. Still, one of the most devastating consequences of radiation to the liver remains a challenge: radiation-induced liver disease (RILD). Here, we will review the current understanding of classic and nonclassic RILD from a clinical perspective, the evaluation and management of patients who are at risk of developing RILD, methods to reduce the likelihood of RILD using modern radiation techniques, and the diagnosis and treatment of radiation-related liver toxicities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30309642      PMCID: PMC6402843          DOI: 10.1016/j.semradonc.2018.06.007

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  28 in total

Review 1.  Radiation dose escalation for locally advanced unresectable intrahepatic and extrahepatic cholangiocarcinoma.

Authors:  Santiago Avila; Danyal A Smani; Eugene J Koay
Journal:  Chin Clin Oncol       Date:  2019-12-19

2.  Antioxidant Properties of Trianthema Portulacastrum and Protection Against Ionizing Radiation-Induced Liver Damage Ex vivo.

Authors:  Uttam Das; Tanmay Saha; Subir Kumar Das
Journal:  Indian J Clin Biochem       Date:  2021-03-08

3.  Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcomes.

Authors:  Masayuki Ueno; Hiroyuki Takabatake; Satoshi Itasaka; Takahisa Kayahara; Youichi Morimoto; Hiroshi Yamamoto; Motowo Mizuno
Journal:  J Gastrointest Oncol       Date:  2021-10

4.  Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.

Authors:  Anthony D Nehlsen; Kunal K Sindhu; Thomas Wolken; Fahad Khan; Christopher K Kyriakakos; Stephen C Ward; Erin Moshier; Bachir Taouli; Michael Buckstein
Journal:  Radiol Imaging Cancer       Date:  2022-07

5.  Functional Liver Imaging in Radiotherapy for Liver Cancer: A Systematic Review and Meta-Analysis.

Authors:  Pi-Xiao Zhou; Ying Zhang; Quan-Bin Zhang; Guo-Qian Zhang; Hui Yu; Shu-Xu Zhang
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 6.  Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity.

Authors:  Shirley Lewis; Laura Dawson; Aisling Barry; Teodor Stanescu; Issa Mohamad; Ali Hosni
Journal:  JHEP Rep       Date:  2022-05-14

7.  Stereotactic Body Radiotherapy Based on 99mTc-GSA SPECT Image-guided Inverse Planning for Hepatocellular Carcinoma.

Authors:  Yudai Kai; Ryo Toya; Tetsuo Saito; Tomohiko Matsuyama; Yoshiyuki Fukugawa; Shinya Shiraishi; Yoshinobu Shimohigashi; Natsuo Oya
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.

Authors:  Jamie M Aye; Wei Xue; Joshua D Palmer; David O Walterhouse; Michael A Arnold; Todd E Heaton; Rajkumar Venkatramani
Journal:  Pediatr Blood Cancer       Date:  2021-01-26       Impact factor: 3.167

Review 9.  Liver-Directed Therapies for Neuroendocrine Neoplasms.

Authors:  Ashley Kieran Clift; Andrea Frilling
Journal:  Curr Oncol Rep       Date:  2021-03-15       Impact factor: 5.075

Review 10.  Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects.

Authors:  Philippe d'Abadie; Michel Hesse; Amandine Louppe; Renaud Lhommel; Stephan Walrand; Francois Jamar
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.